Acorah Software Products - Accounts Production 16.4.675 false true 31 December 2023 4 November 2022 false true No description of principal activity 1 January 2024 31 December 2024 31 December 2024 14462405 Mr E R Charles Dr A Shah iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14462405 2023-12-31 14462405 2024-12-31 14462405 2024-01-01 2024-12-31 14462405 frs-core:CurrentFinancialInstruments 2024-12-31 14462405 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14462405 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 14462405 frs-bus:Micro-entities 2024-01-01 2024-12-31 14462405 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 14462405 frs-bus:Director1 2024-01-01 2024-12-31 14462405 frs-bus:Director2 2024-01-01 2024-12-31 14462405 2022-11-03 14462405 2023-12-31 14462405 2022-11-04 2023-12-31 14462405 frs-core:CurrentFinancialInstruments 2023-12-31
Registered number: 14462405
Codify Therapeutics Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Balance Sheet
Registered number: 14462405
31 December 2024 31 December 2023
£ £
Fixed assets 2,191 3,574
Current assets 885,749 4,377,174
Prepayments and accrued income 782,609 393,355
Creditors: Amounts Falling Due Within One Year (8,332,317 ) (6,236,753 )
NET CURRENT LIABILITIES (6,663,959 ) (1,466,224 )
TOTAL ASSETS LESS CURRENT LIABILITIES (6,661,768 ) (1,462,650 )
Accruals and deferred income (208,487 ) (233,067 )
NET LIABILITIES (6,870,255 ) (1,695,717 )
CAPITAL AND RESERVES (6,870,255 ) (1,695,717 )

Notes

1. General Information
Codify Therapeutics Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14462405 . The registered office is 87 Albert Bridge Road, London, SW11 4PF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
Page 0
Page 1
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors on 29 September 2025 and were signed on its behalf by:
Mr E R Charles
Director
29/09/2025